BeOne Medicines
ONC
#634
Rank
NZ$64.61 B
Marketcap
NZ$583.91
Share price
1.05%
Change (1 day)
47.09%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): NZ$0.30 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are NZ$4.97 Billion. In 2024 the company made an earning of -NZ$0.95 Billion, an increase over its 2023 earnings that were of -NZ$2.02 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.30 B-132.11%
2024 -NZ$0.95 Billion-52.95%
2023 -NZ$2.02 Billion-32.52%
2022 -NZ$2.99 Billion24.39%
2021 -NZ$2.41 Billion-13.21%
2020 -NZ$2.77 Billion72.69%
2019 -NZ$1.61 Billion36.01%
2018 -NZ$1.18 Billion616.83%
2017 -NZ$0.17 Billion-15.24%
2016 -NZ$0.2 Billion107.91%
2015 -NZ$93.22 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.27 Billion-187.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.29 Million-109.94%๐Ÿ‡บ๐Ÿ‡ธ USA